Gujarat Kidney Shares Analyzed
Gujarat Kidney and Super Speciality shares jumped up 9.5% on the stock market today. This means the price of each share went up by that amount. While the overall stock market was slightly down, Gujarat Kidney’s shares were doing really well. It’s important to understand why this happened and what it means for the company.
Key Points
- Gujarat Kidney shares rose 9.5% today, exceeding gains.
- Stock market (BSE) price reached ₹110.8, a peak for the day.
- Overall market down 0.21%, but Gujarat Kidney outperformed.
- Company value: ₹861.76 crore; recent highs & lows noted.
- New acquisitions announced, driving increased investor interest.
- Acquisitions to boost healthcare operations and future growth.
Company Background
Gujarat Kidney and Super Speciality started trading on December 30, 2025. Their shares started at ₹120, which was a bit higher than what they were initially offered at (₹114). This is called a “premium,” and it shows people were excited to buy their stock.
Why the Price Increase?
The main reason the company’s stock went up so much today was because they announced they were buying two other healthcare businesses. First, they’re taking over the rest of a company called Harmony Medicare, making it completely theirs. They paid ₹10.78 crore for this. Harmony Medicare makes about ₹42.29 crore in sales each year.
Second, they’re buying a pharmacy and medical center in Gujarat called Ashwini Medical Centre. They will pay ₹14 crore for this company, with some money already paid and the rest to be paid from money raised when they first sold their stock. Ashwini Medical Centre does about ₹4.51 crore in sales per year.
How the Company Plans to Use the Money
When Gujarat Kidney first sold their stock, they said they would use most of the money to build a new hospital in Vadodara, buy robotic equipment for their hospital, and pay for other things like borrowing money. They also wanted to buy a hospital in Ahmedabad called Parekhs Hospital.
These acquisitions are a big sign that the company is growing and trying to become even stronger in the healthcare industry.
“Smart investments often stem from companies strategically expanding their capabilities.”
